PRECIGEN, INC. XON Cash Flow

Precigen, inc. (XON)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Cash flows from operating activities
Cash flows from operating activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-55,998	-169,215	-53,634	-38,931	-62,136	-341,722	-58,746	-66,829	-47,409	-33,945	-40,836	-19,662	-32,377	-44,912	-30,011	-50,031	-65,320	-33,275	-39,029	-41,494	25,804	17,932	-53,862	-52,935	3,249	-13,018	14,991	-6,519	-36,362
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
4,810	6,185	6,021	6,113	6,577	7,928	8,303	8,499	8,382	8,264	7,990	7,491	7,400	6,915	5,983	6,026	5,648	5,541	4,844	3,809	3,549	3,545	3,097	1,968	1,805	1,744	1,767	1,823	1,871
Loss on disposals of assets, net
-217	-1,196	-589	-793	-493	-16,818	1,475	-5,269	-316	-1,813	-344	-401	-566	-369	-72	-40	-185	-114	-318	-109	-92	-38	-89	-74	-7	-	-	-	-
Gain on sale of discontinued operations
672	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on release of cumulative foreign currency translation adjustments to loss from discontinued operations
-26,957	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized and realized (appreciation) depreciation on equity securities and preferred stock, net
-	-	-	-	-	-	-	-	-	-	-	8,687	-1,622	-	-	-	-22,331	-	-	-	-	-	-	-	-	-	-	-	-
Equity Securities and Preferred Stock, Unrealized and Realized Appreciation (Depreciation)
-106	5,199	-3,068	5,632	70	-2,635	-7,287	-19,182	-1,096	-	-	-	-	-	-	-	-	-	-	-	-	38,475	-37,089	-33,777	21,922	4,739	27,339	7,734	-29,369
Noncash dividend income
-	-	-	-	-	266	4,661	5,031	4,883	4,453	4,323	4,054	3,926	3,745	3,676	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized (appreciation) depreciation on equity securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	115,454	-	-	-	-	-	-	-	-
Amortization of discounts on investments, net
233	56	256	341	352	496	275	0	0	0	-81	-132	-198	-208	-264	-278	-320	-344	-102	-72	-124	-236	-329	-378	-414	-465	-200	-51	0
Income (Loss) from Equity Method Investments
-389	-1,696	-1,647	-1,747	-1,640	-1,728	-2,870	-4,550	-2,460	-3,010	-2,993	-3,333	-4,947	-4,169	-6,255	-5,053	-5,643	-2,379	-2,429	-2,180	-1,956	-1,750	-1,619	-1,355	-536	-216	0	0	-390
Gain on previously held equity investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	7,415
Stock-based compensation expense
4,372	4,412	5,423	61	9,054	7,956	8,132	8,846	11,362	9,627	12,057	11,998	7,894	11,571	10,792	6,651	13,188	12,143	8,385	7,880	10,259	6,977	4,250	6,848	3,774	1,080	645	809	387
Contribution of services by shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	506	508	507	470	387	388	387	388
Shares issued as payment for services
930	2,459	2,299	4,857	831	2,291	2,917	2,546	2,941	2,678	2,730	2,795	2,915	2,493	2,595	2,606	3,083	1,689	0	0	480	-	-	-	-	-	-	-	-
Shares issued to nonemployee members of the Board of Directors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	60	426	-	15	85	0
Shares issued as consideration for license agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	59,579	0	0	0	0	-	-	-	-
Accounts Receivable, Credit Loss Expense (Reversal)
523	2,455	443	280	64	182	808	571	218	124	511	573	9	354	426	343	840	195	578	591	393	491	74	0	0	-	-	-	-
Accretion of debt discount and amortization of deferred financing costs
2,517	2,497	2,430	2,319	2,213	2,262	2,116	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Income Tax Expense (Benefit)
0	-2,226	-467	-473	-508	-1,943	-14,246	-1,015	-4,074	-234	-775	-881	-638	-500	-308	-471	-2,188	743	-578	157	795	0	0	0	0	-	-	-	-
Other noncash items
-239	2,447	-118	-2,931	-235	-458	-430	-78	-127	-1,331	-1,758	3,460	146	-403	-868	-198	-193	-155	237	-278	-264	-479	-173	-36	-35	-	-	-	-3
Receivables:
Trade
-438	503	-3,984	5,049	-1,306	3,097	-4,038	5,495	-1,856	1,751	-4,193	3,633	-1,931	-470	-4,581	5,485	-3,022	124	-115,502	126,701	815	-889	-3,461	110	-92	595	-63	76	36
Related parties
-25	223	-4,507	4,901	-1,584	-4,918	194	-1,550	-4,729	-1,704	-862	-3,059	4,994	634	1,765	-1,625	-7,578	-140	11,395	2,594	-2,807	949	2,149	2,260	759	760	3,718	-2,734	3,223
Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	0	18	12	12	1	-21	4	16	1	0	0	0	-	-	-	-
Other
-1,736	1,118	-166	346	-642	-367	856	-162	215	-124	123	199	-859	110	245	-794	168	1,104	-6,180	-143	-67	-56	-80	17	104	-30	388	202	-18
Inventory
-1,202	675	-1,679	-1,715	-1,381	3,055	-2,145	-201	-231	2,755	-1,418	58	-2,058	876	-2,612	-586	-1,485	4,225	-4,663	830	382	7,895	-582	0	0	-	-	-	-
Prepaid expenses and other
-927	-2,058	4,365	-367	322	-1,517	1,795	-222	-1,062	-1,008	987	-261	-210	-53	2,284	-1,156	-143	-1,276	2,336	1,377	292	-214	444	237	-2	-281	1,375	-638	-109
Right-of-use assets
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-7	-374	-1,161	1,215	-13	-68	-482	-149	47	400	300	-209	526	-55	563	-1,858	-839	-1,698	-1,059	3,660	1,216	9	-18	-34	-37	-40	-7,489	7,589	-42
Accounts payable
-917	-917	-746	-2,449	-1,237	5,411	-263	296	-764	354	36	-2,802	-990	717	67	441	2,393	297	-3,435	-797	672	2,463	-1,536	-177	516	-225	-540	788	-66
Accrued compensation and benefits
-1,941	4,651	882	1,441	-1,788	-13,176	9,964	2,746	4,851	-4,757	2,045	322	924	-4,401	1,542	1,230	-10,773	4,596	1,796	4,396	-297	1,042	1,692	1,333	-2,480	1,468	370	-549	12
Other accrued liabilities
-2,974	135	2,204	-1,726	-6,129	-1,235	2,756	1,308	-2,473	1,453	-443	1,928	69	1,231	2,964	83	4,724	270	484	-371	1,210	234	602	-1,656	234	1,858	-339	-3	42
Deferred revenue
-10,437	2,367	-3,834	7,560	1,330	-15,585	-7,345	-6,025	-9,623	-40,056	-9,487	-12,783	-13,011	-11,382	-8,021	-9,128	3,050	22,034	-8,509	63,530	-2,621	2,298	-2,021	-2,527	23,184	1,723	-8,402	2,255	56
Lease liabilities
-53	2,685	-1,005	-2,704	29	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Related party payables
87	7	-29	-1,849	1,916	115	32	-34	-165	-503	72	123	161	-169	148	123	208	3	-57,437	57,526	-156	-945	-182	37	-47	-29	124	-300	211
Other long-term liabilities
-	-	-	-	-	28	35	84	134	57	662	453	156	20	20	127	-21	-72	-20	31	157	74	-106	-138	10	-99	-140	65	-75
Net cash used in operating activities
-27,743	-32,142	-27,148	-33,403	-43,234	-37,362	-28,820	-28,170	-29,888	-33,880	-22,010	-23,141	-24,689	-17,208	-15,731	-12,440	-3,609	12,332	52,895	-16,517	-13,041	-9,050	-6,637	-13,650	9,479	-10,224	-15,846	-13,334	-14,279
Cash flows from investing activities
Purchases of investments
119,267	0	17,910	37,163	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales and maturities of investments
18,000	-	-	-	45,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of investments
-	-	-	-	-	-	14,975	0	6,000	-	48,300	43,000	45,000	30,000	30,000	23,987	18,000	18,000	22,000	24,000	24,000	24,747	24,498	38,498	35,249	-	-	-	0
Purchases of preferred stock and warrants
-	-	-	-	-	-	-	-	-	0	0	0	1,161	0	1,141	1,167	0	0	2,180	0	14,900	19,496	0	0	0	-	-	-	-
Proceeds from sales of equity securities
0	22,867	0	171	418	0	0	217	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions of businesses, net of cash received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,448	74,979	9,942	29,559	460	62,205	0	4,912	-5	0	0	-512
Investments in affiliates
0	0	1,343	2,000	370	2,443	5,629	3,000	5,510	550	6,060	0	4,579	2,127	4,361	2,333	2,721	8,743	1,365	1,843	1,491	770	605	0	1,500	-	-	-	0
Return of investment in affiliate
-	-	-	-	-	0	0	0	2,598	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid in asset acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	7,244	-	0	0	0	-	-	-	-	-	-	-	-
Purchases of property, plant and equipment
3,152	4,684	7,776	13,900	11,523	11,233	8,765	10,815	10,774	13,991	14,413	11,919	6,343	11,432	10,159	5,781	4,257	2,908	3,101	4,029	2,711	1,181	1,439	769	2,982	265	486	595	181
Proceeds from sale of assets
684	327	185	109	67	337	1,490	210	230	213	308	978	137	31	103	38	102	206	187	39	194	25	0	151	0	-	-	-	-
Proceeds from sale of discontinued operations, net of cash sold
64,240	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuances of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	700	0	0	300
Proceeds from repayment of notes receivable
2,942	-	-	-	0	-	-	-	-	0	0	0	1,500	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from related party notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	500
Net cash provided by (used in) investing activities
-36,553	54,509	13,777	-15,027	33,592	30,741	-161,034	-13,464	-7,456	23,914	28,135	17,729	34,554	16,752	-63,768	14,744	3,880	-1,927	-239,510	8,225	-26,033	10,465	-39,751	-22,598	25,855	-1,959	-126,394	-95,841	531
Cash flows from financing activities
Cash flows from financing activities
Proceeds from issuance of shares in a private placement
35,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	25,000	-	-	-	0
Proceeds from issuance of shares and warrants in public offering, net of issuance costs
0	0	0	0	6,611	0	0	0	87,990	0	0	0	0	-	-	-	-	0	218,193	0	110,041	0	0	0	0	-	-	-	-
Acquisitions of noncontrolling interests
-	-	-	-	-	-	-	-	-	0	0	0	913	0	0	0	0	0	0	0	1,566	0	0	0	0	-	-	-	-
Advances from lines of credit
8,718	7,134	1,373	1,842	1,408	1,330	953	1,039	1,239	1,343	1,239	1,646	1,678	2,767	768	728	812	1,513	2,039	6,121	5,559	3,998	678	0	0	-	-	-	-
Repayments of advances from lines of credit
9,435	5,781	1,191	1,732	1,597	1,064	1,327	786	1,151	1,344	1,290	1,771	2,088	2,496	680	803	837	1,427	2,437	5,869	7,211	2,281	4,213	0	0	-	-	-	-
Proceeds from issuance of subscriptions payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200
Payments of capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	8	-	8	14	20
Proceeds from long-term debt, net of issuance costs
0	0	0	0	376	25,859	194,000	0	0	40	0	159	126	0	547	0	0	0	37	0	44	0	0	120	148	139	183	171	0
Payments of long-term debt
132	154	143	143	178	138	204	141	140	134	133	129	123	353	163	525	160	532	354	337	341	523	156	0	0	-	-	-	-
Payments of deferred consideration for acquisitions
-	-	-	-	-	-	-	-	-	0	6,687	0	1,991	0	6,705	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from stock option and warrant exercises
0	0	6	0	307	1,262	141	609	324	113	189	503	175	985	509	7,894	9,777	2,254	1,826	7,815	2,567	215	298	646	330	359	46	2	7
Payment of stock issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	10	0	0	0	0	-	-	-	-	0	0	0	256	0	0	1,621	1,527
Net cash provided by financing activities
34,151	1,199	45	-33	6,927	27,249	193,600	684	88,262	13,704	-6,682	408	-3,146	903	-5,724	7,294	9,592	242	213,052	7,730	110,659	1,409	-3,376	757	25,214	472	168,999	83,911	63,069
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
-39	33	-425	86	-504	-283	197	-533	914	163	428	-62	526	-560	-151	-250	88	-298	97	446	-36	-62	-37	-56	-5	-2	2	1	0
Net decrease in cash, cash equivalents, and restricted cash
-30,184	23,599	-13,751	-48,377	-3,219	20,345	3,943	-41,483	51,832	3,901	-129	-5,066	7,245	-113	-85,374	9,348	9,951	10,349	26,534	-116	71,549	2,762	-49,801	-35,547	60,543	-11,713	26,761	-25,263	49,321
Supplemental Cash Flow Information [Abstract]
Cash paid during the period for interest
3,568	53	61	3,560	77	3,508	165	113	82	83	388	76	70	89	735	70	70	76	1,020	15	84	111	33	1	13	1	2	46	2
Cash paid during the period for income taxes
40	0	10	10	30	23	30	143	20	69	120	377	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Significant noncash activities
Accrued compensation paid in equity awards
5,100	-	-	-	1,102	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of dividends on redeemable convertible preferred shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	4,044	7,942	6,405
Stock received as consideration for collaboration agreements
-	-	-	-	-	-	-	-	-	-	-	-	-	0	5,100	4,333	9,333	4,482	4,667	0	0	9,021	0	0	5,225	4,456	11,115	1,332	2,400
Stock and warrants issued in business combinations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	56,195	30,933	39,735	0	32,802	-488	19,368	-	-	-	-
Stock issued to acquire noncontrolling interests
-	-	-	-	-	-	-	-	-	0	0	0	5,082	0	0	0	0	0	0	0	9,412	0	0	0	0	-	-	-	-
Stock issued in asset acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	4,401	0	0	0	0	-	-	-	-	-	-	-	-
Contingent consideration assumed in asset acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	3,660	0	0	0	0	-	-	-	-	-	-	-	-
Noncash dividend to shareholders
-	-	-	-	-	-	-	-	-	0	0	0	22,385	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment included in accounts payable and other accrued liabilities
369	2	-318	-1,521	2,531	179	37	35	2,016	120	-1,425	2,430	1,132	-274	-192	279	839	249	-531	1,064	0	-	-	-	-	-	-	-	-
Cash, cash equivalents, and restricted cash
Purchases of equipment financed through debt
-	-	-	-	-	41	117	0	76	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from stock option exercises included in other receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,553	-	-	-	0	-	-	-	-	-	-	-	-
Stock issued and payable in Medistem, Inc. acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0